| Name | Title | Contact Details |
|---|
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
We are foremost a service organization. Our technology, personnel and business exist to serve the requirements of our clients. We believe both forward thinking and responsiveness must be inherent to our operating culture. Railway clients share common issues but are inherently unique in their operations, with widely varying infrastructures, cultures, track conditions, usage, standards, and regulatory oversight. The Sperry Approach is to customize our proprietary capabilities and best-available technologies for programs specific to each railway. We are committed to innovation, an essential element of our operating philosophy and culture. Innovation is ongoing and includes numerous enhancements to improve test accuracy, and speed of testing. In recent years, the company has invested significantly to enhance the usefulness and reliability of its test data with integrated web-based systems, and to improve operating standards through comprehensive training programs and evaluation tools for field personnel. Our overall vision for rail flaw detection services is to transform rail testing from a discrete, event-driven activity to a predictive process fully integrated with proactive, cost-effective rail management programs.
Keybase is a Strongsville, OH-based company in the Business Services sector.
W P I Advertising is a New York, NY-based company in the Business Services sector.
El Clasificado is one of the leading providers in Business Services. It is based in Los Angeles, CA. To find more information about El Clasificado, please visit www.elclasificado.com.